jueves, 13 de marzo de 2025

Olipudase alfa-rpcp (Xenpozyme) A Clinical Dose Escalation Strategy for a Rare Disease Drug Program

https://www.fda.gov/media/185753/download?attachment=&utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario